Get the Stockscreener App
1.37
5.52%
-0.08
Mustang Bio Inc stock is traded at $1.37, with a volume of 78,529.
It is down -5.52% in the last 24 hours and down -13.29% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$1.45
Open:
$1.45
24h Volume:
78,529
Relative Volume:
0.63
Market Cap:
$8.77M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0176
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
-8.67%
1M Performance:
-13.29%
6M Performance:
+25.69%
1Y Performance:
-89.74%
1-Day Range:
$1.36
$1.45
1-Week Range:
$1.36
$1.52
52-Week Range:
$0.8926
$21.95
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Compare MBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.3713 | 10.50M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
Is Mustang Bio Inc. stock affected by interest rate hikesPortfolio Update Summary & Capital Efficiency Focused Strategies - newser.com
Identifying reversal signals in Mustang Bio Inc.Quarterly Profit Report & Safe Capital Preservation Plans - newser.com
Will Mustang Bio Inc. stock return to pre crisis levels2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Smart tools for monitoring Mustang Bio Inc.’s price action2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Can Mustang Bio Inc. stock hit analyst price targets2025 Analyst Calls & Weekly High Return Forecasts - newser.com
Will Mustang Bio Inc. stock see PE expansion2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Will Mustang Bio Inc. stock benefit from upcoming earnings reportsPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Detecting price anomalies in Mustang Bio Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
Will Mustang Bio Inc. price bounce be sustainableJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
How strong is Mustang Bio Inc. stock balance sheetWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com
How Mustang Bio Inc. stock compares to growth peersQuarterly Investment Review & Low Volatility Stock Suggestions - newser.com
How sustainable is Mustang Bio Inc. stock dividend payoutPortfolio Performance Report & Fast Entry High Yield Tips - newser.com
What analysts say about Mustang Bio Inc stockGeopolitical Risk Analysis & High Return Portfolio Growth - earlytimes.in
Can Mustang Bio Inc. stock deliver strong Q4 earnings2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
News impact scoring models applied to Mustang Bio Inc.Market Performance Report & Real-Time Market Sentiment Alerts - newser.com
Is Mustang Bio Inc. still worth holding after the dipGap Down & Weekly Watchlist for Hot Stocks - newser.com
Is Mustang Bio Inc. stock a safe investment in uncertain markets2025 Price Action Summary & Verified Technical Signals - newser.com
Is Mustang Bio Inc a good long term investmentAnalyst Upgrades & Consistent Triple Returns - earlytimes.in
How institutional buying supports Mustang Bio Inc. stockJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):